Caribou Biosciences (CRBU) Stock Price, Quote, News & History | Benzinga

Caribou Biosciences Inc (CRBU) Stock Price, Quote, News & History

CRBUNASDAQ

Trade with Public

Trade with Public

$1.66

-0.13-7.26%

At close: Jun 11, 5:00 PM EST

$1.74

0.084.82%

After Hours: 7:26 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.80

Close

$1.66

Volume / Avg.

2.70M / 1.48M

Day Range

$1.61 - $1.83

52 Wk Range

1.04 - 3.54

Market Cap

$172.57M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

7.82%

Days to Cover

4.05

Recent Caribou Biosciences Inc News

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.

Vandana Singh

Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences, and Corbus Pharmaceuticals with key 2024 data readouts and trials.

Vandana Singh

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-101.25M

Investing Cash Flow (TTM)

76.84M

Financing Cash Flow (TTM)

7.05M

Free Cash Flow (TTM)

-101.64M

Capital Expenditure (TTM)

-389.00K

Net Change in Cash (TTM)

-17.36M

Analyst Trends and Forecast

1

Feb

1

Mar

1

Apr

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$85.86M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

14.96

PB Ratio (TTM)

1.73

Earnings Yield % (TTM)

-79.78%

Earnings Yield % (FWD)

-64.61%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.03

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.06M

Debt to Equity

0.26

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.80

Close

$1.66

Volume / Avg.

2.70M / 1.48M

Day Range

$1.61 - $1.83

52 Wk Range

1.04 - 3.54

Market Cap

$172.57M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

7.82%

Days to Cover

4.05

About

Sector

Health Care

Industry

Biotechnology

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The compa...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Caribou Biosciences (CRBU) stock?

A

You can purchase shares of Caribou Biosciences (NASDAQ:CRBU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Caribou Biosciences (CRBU) competitors?

A

There are no as such competitors for Caribou Biosciences.

Q

What is the forecast, or price target, for Caribou Biosciences (CRBU) stock?

A

Caribou Biosciences has a consensus price target of $12.71.

Q

What is the current price for Caribou Biosciences (CRBU)?

A

The stock price for Caribou Biosciences (NASDAQ: CRBU) is $1.74 last updated June 11, 2026 at 7:26 PM EDT.

Q

Does Caribou Biosciences (CRBU) pay a dividend?

A

There are no upcoming dividends for Caribou Biosciences.

Q

When is Caribou Biosciences (NASDAQ:CRBU) reporting earnings?

A

Caribou Biosciences does not have any upcoming earnings scheduled.

Q

Is Caribou Biosciences (CRBU) going to split?

A

There is no upcoming split for Caribou Biosciences.

Q

What sector and industry does Caribou Biosciences (CRBU) operate in?

A

Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.